# U.S. drugmaker Eli Lilly is in advanced talks to acquire biotech firm Kelonia Therapeutics for more than $2 billion.

*business · news · 2026-04-19 · CNBC*

## Key points

- Eli Lilly is in advanced negotiations to acquire Kelonia Therapeutics for over $2 billion.
- The deal may include milestone-based additional payments linked to Kelonia's clinical progress.
- An acquisition announcement could occur as soon as Monday, per The Wall Street Journal.
- Kelonia specializes in clinical-stage genetic medicines, with a focus on CAR-T cell therapies.

**Companies:** Eli Lilly, Kelonia Therapeutics
**Countries:** United States

[Read the full story on CNBC](https://www.cnbc.com/2026/04/19/eli-lilly-kelonia-therapeutics.html)

---

Canonical: https://newsio.io/n/9ee71b30-0860-40b8-a0bb-c2252be1a92a/u-s-drugmaker-eli-lilly-is-in-advanced-talks-to-acquire-biotech-firm-kelonia-the
Summarized by Newsio from CNBC. https://newsio.io/how-it-works